BLACK WEEKSViale −15 % · kompleti −10 % · ostalo −5 %s kodoBrezplačna dostava v Nemčiji od 200 €

Ta stran je bila prevedena samodejno in lahko vsebuje napake. Ste materni govorec? Veseli bomo vaših povratnih informacij in popravkov.Pošljite povratne informacije

The Peptide Desk The Peptide Desk
Ovagen, fotografija izdelka
Bioregulators

Ovagen

Bioregulators

  • Odprema iz Nemčije

Naročilo

Cena na kos - Brezplačna dostava v Nemčiji od 200 € med Black Weeks
  • DHL s sledenjem
  • Diskretna embalaža

4.6 od 5 na Trustpilotu73 ocen

Na prvi pogled

Ovagen v številkah

Ključni podatki iz našega leksikona.

Celoten vnos v leksikonu
Class
Short bioregulator peptideKhavinson cytogen
Use
Subcutaneousin mg
Sizes
20 mg1 size in the shop

Znanje

Vse o Ovagen

Priporočljivo zraven

Kaj potrebujete zraven

Bakteriostatska voda se samodejno doda v vašo košarico. Brizge in robčki z enim klikom.

Inzulinske brizge

10 kos. · 5.50 €

Alkoholni robčki

50 kos. · 10 €

Koliko vode?

Enote na brizgi za vašo velikost viale.

Odpri kalkulator →

FAQ

Pogosta vprašanja

Viri za vsak odgovor: vnos v leksikonu

Imate še vprašanje?

Pišite nam, naša ekipa vam bo pomagala.

What is Ovagen?

According to a review by the Khavinson group, the tripeptide Glu-Asp-Leu (EDL). The group lists it as a protective peptide for the kidneys and liver. PubMed has no study under the name Ovagen, the papers call it EDL or T-35.

What do the studies on EDL show?

In rats with kidney damage from the antibiotic gentamicin or from interrupted blood flow, EDL prevented a drop in urine output and a build-up of waste products. Protein and sodium in the urine fell, antioxidant enzymes did not drop critically. The abstract gives no percentages.

How well is the effect on the liver supported?

Weakly. For the liver the review cites a patent of the group as evidence, no published study with EDL in the liver was found. The related short peptide Livagen stimulated the growth of liver tissue pieces in tissue culture.

How is Ovagen supposed to work?

The Khavinson group suggests that short peptides reach the cell nucleus and bind to DNA. Modelled on the computer, EDL bound the same DNA sequence as Bronchogen and could enter cells via the transporter LAT1. In kidney cell cultures the enzyme MMP-14 was its target. This is only shown in models and cell cultures.

Has Ovagen been studied in humans?

No. ClinicalTrials.gov lists no trial with Ovagen or EDL (as of 26 Oct 2026). The 2002 review describes clinical use of tissue extracts such as Epithalamin and Thymalin, not of Ovagen.

Which side effects are known?

There are no solid data because Ovagen has never been tested in a registered human trial. Missing reports are not proof of safety.

Sorodno

Sorodni izdelki